- Home
- REE vs CTXR Comparison
REE vs CTXR Comparison
Compare REE & CTXR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- REE
- CTXR
- Stock Information
- Founded
- REE 2011
- CTXR 2007
- Country
- REE Israel
- CTXR United States
- Employees
- REE N/A
- CTXR N/A
- Industry
- REE Auto Manufacturing
- CTXR Biotechnology: Pharmaceutical Preparations
- Sector
- REE Consumer Discretionary
- CTXR Health Care
- Exchange
- REE Nasdaq
- CTXR Nasdaq
- Market Cap
- REE 18.5M
- CTXR 20.8M
- IPO Year
- REE N/A
- CTXR N/A
- Fundamental
- Price
- REE $0.74
- CTXR $1.17
- Analyst Decision
- REE Strong Buy
- CTXR Strong Buy
- Analyst Count
- REE 2
- CTXR 3
- Target Price
- REE $11.75
- CTXR $53.00
- AVG Volume (30 Days)
- REE 64.7K
- CTXR 461.3K
- Earning Date
- REE 09-16-2025
- CTXR 08-12-2025
- Dividend Yield
- REE N/A
- CTXR N/A
- EPS Growth
- REE N/A
- CTXR N/A
- EPS
- REE N/A
- CTXR N/A
- Revenue
- REE $183,000.00
- CTXR N/A
- Revenue This Year
- REE $6,661.20
- CTXR N/A
- Revenue Next Year
- REE $2,240.01
- CTXR $851.67
- P/E Ratio
- REE N/A
- CTXR N/A
- Revenue Growth
- REE N/A
- CTXR N/A
- 52 Week Low
- REE $0.53
- CTXR $0.65
- 52 Week High
- REE $11.72
- CTXR $15.25
- Technical
- Relative Strength Index (RSI)
- REE 56.88
- CTXR 42.40
- Support Level
- REE $0.68
- CTXR $1.13
- Resistance Level
- REE $0.75
- CTXR $1.25
- Average True Range (ATR)
- REE 0.04
- CTXR 0.08
- MACD
- REE 0.01
- CTXR -0.00
- Stochastic Oscillator
- REE 72.73
- CTXR 14.89
About REE REE Automotive Ltd.
REE Automotive Ltd is an automotive technology company focused on building commercial electric vehicles controlled fully by-wire. The company is in early stages of commercialization and develop and produce software-defined vehicle (SDV) technology that manages vehicle operations and features through proprietarily-developed software. The company has geographical preference in Israel, Germany, United States, United Kingdom, and other regions.
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. The company is currently advancing four proprietary product candidates namely, LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma. Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections, Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries, Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids, and others.